Standout Papers

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Har... 2006 2026 2012 2019 1.4k
  1. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK (2009)
    Alice T. Shaw, Beow Y. Yeap et al. Journal of Clinical Oncology
  2. Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers (2012)
    Ryohei Katayama, Alice T. Shaw et al. Science Translational Medicine
  3. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis (2011)
    Tooru Shimosegawa, Suresh T. Chari et al. Pancreas
  4. Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases (2006)
    Jean‐Nicolas Vauthey, Timothy M. Pawlik et al. Journal of Clinical Oncology
  5. EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib (2012)
    Ryan B. Corcoran, Hiromichi Ebi et al. Cancer Discovery
  6. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake (2012)
    Ömer Yılmaz, Pekka Katajisto et al. Nature
  7. Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population (2009)
    Scott J. Rodig, Mari Mino–Kenudson et al. Clinical Cancer Research
  8. ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer (2013)
    Justin F. Gainor, Anna M. Varghese et al. Clinical Cancer Research
  9. CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors (2014)
    Sadhna Vora, Dejan Juric et al. Cancer Cell

Immediate Impact

5 by Nobel laureates 15 from Science/Nature 102 standout
Sub-graph 1 of 19

Citing Papers

Cellular ATP demand creates metabolically distinct subpopulations of mitochondria
2024 StandoutNature
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
23 intermediate papers

Works of Mari Mino–Kenudson being referenced

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
2022
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment
2016
and 14 more

Author Peers

Author Last Decade Papers Cites
Mari Mino–Kenudson 13430 9759 8194 412 23.7k
Daniel G. Coit 17565 7636 6243 324 27.3k
Susan Groshen 11800 6132 11439 468 31.2k
Gregory Y. Lauwers 11002 7016 13288 444 27.9k
Masazumi Tsuneyoshi 7475 8170 5953 574 21.9k
Christopher L. Corless 5773 16635 9665 318 30.3k
Helmut Friess 12161 3696 6829 349 21.4k
Anthony T.�C. Chan 11344 5465 7002 453 26.8k
Volkan Adsay 18975 4351 12147 329 24.4k
Leslie H. Sobin 8203 14073 13948 215 30.9k
Patrick Schöffski 9407 9276 3130 500 18.9k

All Works

Loading papers...

Rankless by CCL
2026